SCN2A-DEE

Clinical trials for SCN2A-DEE explained in plain language.

Never miss a new study

Get alerted when new SCN2A-DEE trials appear

Sign up with your email to follow new studies for SCN2A-DEE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a new drug tame severe childhood epilepsy?

Disease control Ongoing

This trial is testing an experimental drug called PRAX-222 in children aged 2 to 18 who have a rare, severe form of epilepsy caused by changes in the SCN2A gene. The goal is to see if the drug is safe and can reduce how often seizures happen. Participants will receive either PRAX…

Matched conditions: SCN2A-DEE

Phase: PHASE1, PHASE2 • Sponsor: Praxis Precision Medicines • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

SCN2A-DEE

Get alerted when new SCN2A-DEE trials appear

Can a new drug tame severe childhood epilepsy?